CNBX Pharmaceuticals Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

295.15K

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2025	-	-	-
Aug 31, 2024	130.07K	-280.09K	-68.29%
Aug 31, 2023	410.17K	380.21K	1,269.13%
Aug 31, 2022	29.96K	-	-
Aug 31, 2021	-	-	-
Aug 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Aug 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Aug 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Aug 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Aug 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sorrento Therapeutics	64.27M
EV Biologics	9.47M
Regenerative Medical Technology Group	5.04M
Helix BioMedix	2.07M
Orgenesis	1.04M
Regen BioPharma	236.56K
THC Farmaceuticals	18.52K

Revenue Rankings

CNBX Pharmaceuticals News

3 years ago - CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma - PRNewsWire
3 years ago - CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy - PRNewsWire
3 years ago - CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel - PRNewsWire
3 years ago - CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate - PRNewsWire
3 years ago - CNBX Pharmaceuticals Announces New Patent Granted in Australia - PRNewsWire
4 years ago - CNBX Pharmaceuticals Granted Patent in Hong Kong - PRNewsWire
4 years ago - Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals - PRNewsWire
4 years ago - CNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase I/II (a) Clinical Trials - PRNewsWire

More News